Skip to main content
Top
Published in: Diabetologia 12/2008

01-12-2008 | Review

Imaging the pancreas: from ex vivo to non-invasive technology

Authors: D. Holmberg, U. Ahlgren

Published in: Diabetologia | Issue 12/2008

Login to get access

Abstract

While many recently published reviews have covered non-invasive nuclear imaging techniques, the aim of this review is to focus on current developments in optical imaging technologies for investigating the pancreas. Several of these modalities are being developed into non-invasive, real-time monitoring routines for pancreatic diseases. However, they also provide pre-clinical ex vivo and/or intravital tools for three-dimensional quantitative assessments of cellular and molecular events, with levels of specificity and resolution difficult to achieve with other currently available modalities.
Literature
1.
go back to reference Skau M, Pakkenberg B, Buschard K, Bock T (2001) Linear correlation between the total islet mass and the volume-weighted mean islet volume. Diabetes 50:1763–1770PubMedCrossRef Skau M, Pakkenberg B, Buschard K, Bock T (2001) Linear correlation between the total islet mass and the volume-weighted mean islet volume. Diabetes 50:1763–1770PubMedCrossRef
2.
go back to reference Souza F, Freeby M, Hultman K et al (2006) Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas. Curr Med Chem 13:2761–2773PubMedCrossRef Souza F, Freeby M, Hultman K et al (2006) Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas. Curr Med Chem 13:2761–2773PubMedCrossRef
3.
go back to reference Virostko J, Jansen ED, Powers AC (2006) Current status of imaging pancreatic islets. Curr Dia Rep 6:328–332CrossRef Virostko J, Jansen ED, Powers AC (2006) Current status of imaging pancreatic islets. Curr Dia Rep 6:328–332CrossRef
4.
go back to reference Eich T, Eriksson O, Sundin A et al (2007) Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 84:893–898PubMedCrossRef Eich T, Eriksson O, Sundin A et al (2007) Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 84:893–898PubMedCrossRef
5.
go back to reference Paty BW, Bonner-Weir S, Laughlin MR, McEwan AJ, Shapiro AM (2004) Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation 77:1133–1137PubMedCrossRef Paty BW, Bonner-Weir S, Laughlin MR, McEwan AJ, Shapiro AM (2004) Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation 77:1133–1137PubMedCrossRef
6.
go back to reference Turvey SE, Swart E, Denis MC et al (2005) Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 115:2454–2461PubMedCrossRef Turvey SE, Swart E, Denis MC et al (2005) Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 115:2454–2461PubMedCrossRef
7.
go back to reference Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A (2006) In vivo imaging of islet transplantation. Nat Med 12:144–148PubMedCrossRef Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A (2006) In vivo imaging of islet transplantation. Nat Med 12:144–148PubMedCrossRef
8.
go back to reference Jirak D, Kriz J, Herynek V et al (2004) MRI of transplanted pancreatic islets. Magn Reson Med 52:1228–1233PubMedCrossRef Jirak D, Kriz J, Herynek V et al (2004) MRI of transplanted pancreatic islets. Magn Reson Med 52:1228–1233PubMedCrossRef
9.
go back to reference Kriz J, Jirak D, White D, Foster P (2008) Magnetic resonance imaging of pancreatic islets transplanted into the right liver lobes of diabetic mice. Transplant Proc 40:444–448PubMedCrossRef Kriz J, Jirak D, White D, Foster P (2008) Magnetic resonance imaging of pancreatic islets transplanted into the right liver lobes of diabetic mice. Transplant Proc 40:444–448PubMedCrossRef
10.
go back to reference Hardy OT, Hernandez-Pampaloni M, Saffer JR et al (2007) Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 92:4706–4711PubMedCrossRef Hardy OT, Hernandez-Pampaloni M, Saffer JR et al (2007) Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 92:4706–4711PubMedCrossRef
11.
go back to reference Harris PE, Ferrara C, Baraba P, Polito T, Freeby M, Maffei A (2008) VMAT2 gene expression and function as it applies to imaging of β-cell mass. J Mol Med 86:5–16PubMedCrossRef Harris PE, Ferrara C, Baraba P, Polito T, Freeby M, Maffei A (2008) VMAT2 gene expression and function as it applies to imaging of β-cell mass. J Mol Med 86:5–16PubMedCrossRef
12.
go back to reference Park SY, Wang X, Chen Z et al (2005) Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis 43:80–86PubMedCrossRef Park SY, Wang X, Chen Z et al (2005) Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis 43:80–86PubMedCrossRef
13.
go back to reference Smith SJ, Zhang H, Clermont AO et al (2006) In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. Mol Imaging 5:65–75PubMed Smith SJ, Zhang H, Clermont AO et al (2006) In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. Mol Imaging 5:65–75PubMed
14.
go back to reference Chen X, Zhang X, Larson CS, Baker MS, Kaufman DB (2006) In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation 81:1421–1427PubMedCrossRef Chen X, Zhang X, Larson CS, Baker MS, Kaufman DB (2006) In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation 81:1421–1427PubMedCrossRef
15.
go back to reference Fowler M, Virostko J, Chen Z et al (2005) Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 79:768–776PubMedCrossRef Fowler M, Virostko J, Chen Z et al (2005) Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 79:768–776PubMedCrossRef
16.
go back to reference Lu Y, Dang H, Middleton B et al (2004) Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther 9:428–435PubMedCrossRef Lu Y, Dang H, Middleton B et al (2004) Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther 9:428–435PubMedCrossRef
17.
go back to reference Lee MH, Lee WH, Van Y, Contag CH, Liu CP (2007) Image-guided analyses reveal that non-CD4 splenocytes contribute to CD4+ T cell-mediated inflammation leading to islet destruction by altering their local function and not systemic trafficking patterns. Mol Imaging 6:369–383PubMed Lee MH, Lee WH, Van Y, Contag CH, Liu CP (2007) Image-guided analyses reveal that non-CD4 splenocytes contribute to CD4+ T cell-mediated inflammation leading to islet destruction by altering their local function and not systemic trafficking patterns. Mol Imaging 6:369–383PubMed
18.
go back to reference Roth DJ, Jansen ED, Powers AC, Wang TG (2006) A novel method of monitoring response to islet transplantation: bioluminescent imaging of an NF-κB transgenic mouse model. Transplantation 81:1185–1190PubMedCrossRef Roth DJ, Jansen ED, Powers AC, Wang TG (2006) A novel method of monitoring response to islet transplantation: bioluminescent imaging of an NF-κB transgenic mouse model. Transplantation 81:1185–1190PubMedCrossRef
19.
go back to reference Virostko J, Chen Z, Fowler M, Poffenberger G, Powers AC, Jansen ED (2004) Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants. Mol Imaging 3:333–342PubMedCrossRef Virostko J, Chen Z, Fowler M, Poffenberger G, Powers AC, Jansen ED (2004) Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants. Mol Imaging 3:333–342PubMedCrossRef
20.
go back to reference Brelje TC, Scharp DW, Sorenson RL (1989) Three-dimensional imaging of intact isolated islets of Langerhans with confocal microscopy. Diabetes 38:808–814PubMedCrossRef Brelje TC, Scharp DW, Sorenson RL (1989) Three-dimensional imaging of intact isolated islets of Langerhans with confocal microscopy. Diabetes 38:808–814PubMedCrossRef
21.
go back to reference Jorgensen MC, Ahnfelt-Ronne J, Hald J, Madsen OD, Serup P, Hecksher-Sorensen J (2007) An illustrated review of early pancreas development in the mouse. Endocr Rev 28:685–705PubMedCrossRef Jorgensen MC, Ahnfelt-Ronne J, Hald J, Madsen OD, Serup P, Hecksher-Sorensen J (2007) An illustrated review of early pancreas development in the mouse. Endocr Rev 28:685–705PubMedCrossRef
22.
go back to reference Denk W, Strickler JH, Webb WW (1990) Two-photon laser scanning fluorescence microscopy. Science 248:73–76PubMedCrossRef Denk W, Strickler JH, Webb WW (1990) Two-photon laser scanning fluorescence microscopy. Science 248:73–76PubMedCrossRef
23.
go back to reference Martinic MM, von Herrath MG (2008) Real-time imaging of the pancreas during development of diabetes. Immunol Rev 221:200–213PubMedCrossRef Martinic MM, von Herrath MG (2008) Real-time imaging of the pancreas during development of diabetes. Immunol Rev 221:200–213PubMedCrossRef
24.
go back to reference Speier S, Nyqvist D, Cabrera O et al (2008) Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 14:574–578PubMedCrossRef Speier S, Nyqvist D, Cabrera O et al (2008) Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 14:574–578PubMedCrossRef
25.
go back to reference Sharpe J, Ahlgren U, Perry P et al (2002) Optical projection tomography as a tool for 3D microscopy and gene expression studies. Science 296:541–545PubMedCrossRef Sharpe J, Ahlgren U, Perry P et al (2002) Optical projection tomography as a tool for 3D microscopy and gene expression studies. Science 296:541–545PubMedCrossRef
27.
go back to reference Asayesh A, Sharpe J, Watson RP et al (2006) Spleen versus pancreas: strict control of organ interrelationship revealed by analyses of Bapx1 −/− mice. Genes Dev 20:2208–2213PubMedCrossRef Asayesh A, Sharpe J, Watson RP et al (2006) Spleen versus pancreas: strict control of organ interrelationship revealed by analyses of Bapx1 −/− mice. Genes Dev 20:2208–2213PubMedCrossRef
28.
go back to reference Hecksher-Sorensen J, Watson RP, Lettice LA et al (2004) The splanchnic mesodermal plate directs spleen and pancreatic laterality, and is regulated by Bapx1/Nkx3.2. Development 131:4665–4675PubMedCrossRef Hecksher-Sorensen J, Watson RP, Lettice LA et al (2004) The splanchnic mesodermal plate directs spleen and pancreatic laterality, and is regulated by Bapx1/Nkx3.2. Development 131:4665–4675PubMedCrossRef
29.
go back to reference Alanentalo T, Asayesh A, Morrison H et al (2007) Tomographic molecular imaging and 3D quantification within adult mouse organs. Nat Methods 4:31–33PubMedCrossRef Alanentalo T, Asayesh A, Morrison H et al (2007) Tomographic molecular imaging and 3D quantification within adult mouse organs. Nat Methods 4:31–33PubMedCrossRef
30.
go back to reference Boot M, Westerberg H, Sanz-Esquerro J et al (2008) In vitro whole-organ imaging: 4D quantification of growing mouse limb buds. Nat Methods 5:609–612PubMedCrossRef Boot M, Westerberg H, Sanz-Esquerro J et al (2008) In vitro whole-organ imaging: 4D quantification of growing mouse limb buds. Nat Methods 5:609–612PubMedCrossRef
31.
32.
go back to reference Masci E, Mangiavillano B, Albarello L, Mariani A, Doglioni C, Testoni PA (2007) Pilot study on the correlation of optical coherence tomography with histology in celiac disease and normal subjects. J Gastroenterol Hepatol 22:2256–2260PubMedCrossRef Masci E, Mangiavillano B, Albarello L, Mariani A, Doglioni C, Testoni PA (2007) Pilot study on the correlation of optical coherence tomography with histology in celiac disease and normal subjects. J Gastroenterol Hepatol 22:2256–2260PubMedCrossRef
33.
go back to reference Testoni PA, Mariani A, Mangiavillano B, Arcidiacono PG, Di Pietro S, Masci E (2007) Intraductal optical coherence tomography for investigating main pancreatic duct strictures. Am J Gastroenterol 102:269–274PubMedCrossRef Testoni PA, Mariani A, Mangiavillano B, Arcidiacono PG, Di Pietro S, Masci E (2007) Intraductal optical coherence tomography for investigating main pancreatic duct strictures. Am J Gastroenterol 102:269–274PubMedCrossRef
34.
go back to reference Leitgeb RA, Villiger M, Bachmann AH, Steinmann L, Lasser T (2006) Extended focus depth for Fourier domain optical coherence microscopy. Opt Lett 31:2450–2452PubMedCrossRef Leitgeb RA, Villiger M, Bachmann AH, Steinmann L, Lasser T (2006) Extended focus depth for Fourier domain optical coherence microscopy. Opt Lett 31:2450–2452PubMedCrossRef
Metadata
Title
Imaging the pancreas: from ex vivo to non-invasive technology
Authors
D. Holmberg
U. Ahlgren
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1140-7

Other articles of this Issue 12/2008

Diabetologia 12/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine